Jason A. Keyes
Chief Financial Officer · BlossomHill Therapeutics, Inc.
- 2024
- Aug 10, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jason A. Keyes files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- ORBIMED ADVISORS LLC - $10.00M in BLSM purchases and sales in the last 12 months
- Carl L. Gordon - $10.00M in BLSM purchases and sales in the last 12 months
- Bihua Chen - $5.00M in BLSM purchases and sales in the last 12 months
- John P. Schmid - $96K in BLSM purchases and sales in the last 12 months
- Vincent Paul Liptak - $75K in BLSM purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jason A. Keyes?
Jason A. Keyes is a corporate insider, tracked as Chief Financial Officer of BlossomHill Therapeutics, Inc. (BLSM). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jason A. Keyes submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jason A. Keyes been buying or selling stock?
Recorded transactions: 1 open-market purchase ($11K) and 1 open-market sale ($7K) across all tracked filings.
